UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Volltextzugriff (PDF)

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review

JAMA : the journal of the American Medical Association, 2020-05, Vol.323 (18), p.1824

2020

Volltextzugriff (PDF)

Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant Pseudomonas aeruginosa

Pharmacology, 2018-01, Vol.101 (5-6), p.278-284

2018

Volltextzugriff (PDF)

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients

Microbiology spectrum, 2023-12, Vol.11 (6), p.e0304723-e0304723

2023

Volltextzugriff (PDF)

Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models

Pharmacology, 2018-01, Vol.101 (5-6), p.255-261

2018

Volltextzugriff (PDF)

A case-control study evaluating the unnecessary use of intravenous broad-spectrum antibiotics in presumed sepsis and septic-shock patients in the emergency department

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022, Vol.2 (1), p.e193-e193, Article e193

2022

Volltextzugriff (PDF)

Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia

Journal of infection and public health, 2018-09, Vol.11 (5), p.727-731

2018

Volltextzugriff (PDF)

Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2018-04, Vol.73 (4), p.942-952

2018

Volltextzugriff (PDF)

Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults

Journal of global antimicrobial resistance., 2022-03, Vol.28, p.67-70

2022

Volltextzugriff (PDF)

In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Volltextzugriff (PDF)

In Vivo Efficacy of Meropenem with a Novel Non-β-Lactam-β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model

Antimicrobial agents and chemotherapy, 2018-09, Vol.62 (9)

2018

Volltextzugriff (PDF)

Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model

International journal of antimicrobial agents, 2018-02, Vol.51 (2), p.206-212

2018

Volltextzugriff (PDF)

Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms

Antimicrobial agents and chemotherapy, 2016-08, Vol.60 (8), p.5001-5005

2016

Volltextzugriff (PDF)

Bronchoalveolar Lavage Gram Stains for Early Bacterial Identification in Pneumonia: Should They Stay or Should They Go?

Critical care explorations, 2021-08, Vol.3 (8), p.e0501-e0501

2021

Volltextzugriff (PDF)

Efficacy of Humanized Cefiderocol Exposures over 72 Hours against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model

Antimicrobial agents and chemotherapy, 2019-02, Vol.63 (2)

2019

Volltextzugriff (PDF)

Pharmacokinetics-pharmacodynamics of β-lactamase inhibitors: are we missing the target?

Expert review of anti-infective therapy, 2019-08, Vol.17 (8), p.571-582

2019

Volltextzugriff (PDF)

The role of tazobactam‐based combinations for the management of infections due to extended‐spectrum β‐lactamase‐producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists

Pharmacotherapy, 2021-10, Vol.41 (10), p.864-880

2021

Volltextzugriff (PDF)

Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In Vivo

Antimicrobial agents and chemotherapy, 2016-08, Vol.60 (8), p.5072-5075

2016

Volltextzugriff (PDF)

Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Volltextzugriff (PDF)

Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6578-6584

2016

Volltextzugriff (PDF)

Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic analysis

International journal of antimicrobial agents, 2018-05, Vol.51 (5), p.727-732

2018

Volltextzugriff (PDF)

Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimens

Journal of antimicrobial chemotherapy, 2022-11, Vol.77 (12), p.3321-3330

2022

Volltextzugriff (PDF)

Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Minimal Cerebrospinal Fluid Concentration of Miltefosine despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis

Antimicrobial agents and chemotherapy, 2019-12, Vol.64 (1)

2019

Volltextzugriff (PDF)

Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Pharmacology & Pharmacy
(23)
Microbiology
(20)
Humans
(13)
Infectious Diseases
(11)
Microbial Sensitivity Tests
(10)
Animals
(9)
Anti-Bacterial Agents
(9)
Anti-Bacterial Agents - Pharmacology
(8)
Pharmacokinetics
(7)
Cephalosporins
(6)
Drug Resistance, Multiple, Bacterial
(6)
Female
(6)
Mice
(6)
Pharmacodynamics
(6)
Anti-Bacterial Agents - Pharmacokinetics
(5)
Cefiderocol
(5)
Gram-Negative Bacteria
(5)
Gram-Negative Bacteria - Drug Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review

Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant Pseudomonas aeruginosa

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients

Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models

A case-control study evaluating the unnecessary use of intravenous broad-spectrum antibiotics in presumed sepsis and septic-shock patients in the emergency department

Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia

Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa

Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults

In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model

In Vivo Efficacy of Meropenem with a Novel Non-β-Lactam-β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model

Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model

Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms

Bronchoalveolar Lavage Gram Stains for Early Bacterial Identification in Pneumonia: Should They Stay or Should They Go?

Efficacy of Humanized Cefiderocol Exposures over 72 Hours against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model

Pharmacokinetics-pharmacodynamics of β-lactamase inhibitors: are we missing the target?

The role of tazobactam‐based combinations for the management of infections due to extended‐spectrum β‐lactamase‐producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists

Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In Vivo

Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection

Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation

Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic analysis

Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimens

Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis

Minimal Cerebrospinal Fluid Concentration of Miltefosine despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis

Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers

Suchergebnisse filtern